J I Bell - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J I Bell

Showing results (91-100 of 143) with videos related to

Pageof 15

Sort By:

Immunity|March 1, 1996

An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501K J Smith, S W Reid, D I Stuart, et al.

Lancet (London, England)|January 7, 1995

Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposureY M Lo, S Darby, L Noakes, et al.

British Medical Journal (Clinical Research Ed.)|February 19, 1983

Maturity onset diabetes of the young is not linked to the insulin geneJ I Bell, J S Wainscoat, J M Old, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998

Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAILJ Mongkolsapaya, A E Cowper, X N Xu, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985

DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotypeJ I Bell, P Estess, T St John, et al.

Human Immunology|January 1, 1992

Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplantsW M Rosenberg, A Bushell, R M Higgins, et al.

Immunity|March 1, 1996

Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53K J Smith, S W Reid, K Harlos, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicingG R Screaton, X N Xu, A L Olsen, et al.

Clinical Endocrinology|October 27, 2001

Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid diseaseP J Hunt, S E Marshall, A P Weetman, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donorsP A Moss, S L Rowland-Jones, P M Frodsham, et al.

Pageof 15

Search research articles

Showing results (91-100 of 143) with videos related to

Sort By:

Pageof 15

Immunity|March 1, 1996

An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501K J Smith, S W Reid, D I Stuart, et al.

Lancet (London, England)|January 7, 1995

Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposureY M Lo, S Darby, L Noakes, et al.

British Medical Journal (Clinical Research Ed.)|February 19, 1983

Maturity onset diabetes of the young is not linked to the insulin geneJ I Bell, J S Wainscoat, J M Old, et al.

Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998

Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAILJ Mongkolsapaya, A E Cowper, X N Xu, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985

DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotypeJ I Bell, P Estess, T St John, et al.

Human Immunology|January 1, 1992

Isolated HLA-DP mismatches between donors and recipients do not influence the function or outcome of renal transplantsW M Rosenberg, A Bushell, R M Higgins, et al.

Immunity|March 1, 1996

Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53K J Smith, S W Reid, K Harlos, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997

LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicingG R Screaton, X N Xu, A L Olsen, et al.

Clinical Endocrinology|October 27, 2001

Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid diseaseP J Hunt, S E Marshall, A P Weetman, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995

Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donorsP A Moss, S L Rowland-Jones, P M Frodsham, et al.

Pageof 15